Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. - Wikidata - awgldk - TriplyDB

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

http://www.wikidata.org/entity/Q53344190

about

Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children Regular treatment with formoterol for chronic asthma: serious adverse events Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid Long-acting beta2-agonists for stable chronic asthma Asthma exacerbations . 1: epidemiology Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review Revisiting early intervention in adult asthma Predictors of Symptoms Are Different From Predictors of Severe Exacerbations From Asthma in Children Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study.What is new with the beta2-agonists: issues in the management of asthma.Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study Living with asthma and chronic obstructive airways disease: Using technology to support self-management - An overview.Inhaled Corticosteroids Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.Outcome measures in asthma.Low dose inhaled corticosteroids and the prevention of death from asthma.Long-acting inhaled beta(2)-agonist therapy in asthma.Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.Combined budesonide/formoterol turbuhaler treatment of asthma.New therapies and management strategies in the treatment of asthma: patient-focused developments.The role of inflammation resolution speed in airway smooth muscle mass accumulation in asthma: insight from a theoretical model.Treatment compliance, passive smoking, and asthma control: a three year cohort study Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

P2860

Q24197662-94DE0E51-C106-4032-9EC9-87C52F7D9829 Q24200353-D96E72F7-D846-49C2-A2A9-A078A708241D Q24202005-F23A4FA0-E4B4-4586-BA2B-115EB6C81C50 Q24235303-D4CA9A28-5C1B-40FF-B5C7-2D51E4BBCA65 Q24235964-7A26A376-D25A-4330-B013-AFB61A98E6AD Q24240464-59CC47D3-380B-41AA-99FB-FE732535B198 Q24241025-382997B0-90FA-419E-9649-E146D4D8512E Q24241453-956CA5BD-8A31-43FB-85FE-9A304E8A19A7 Q24241556-B0ACB694-FEEE-49A3-AB64-C1DDA3FFFAB0 Q24245383-B66532A7-BCF4-4D58-A709-1945E18E5EF9 Q24245643-9B47F1C3-0678-4EB9-81E7-7BBDE382F526 Q24245719-6C3D8228-2A77-4C0F-8B21-54500732F1D5 Q24245892-D0F3C7D3-43FC-4810-9DF9-3A53C888774A Q24246441-47ABFB48-5C9C-43E0-875E-45BCA7702272 Q24247926-C4985A5F-B7A0-4188-AB64-02A36A79EE15 Q24683608-3FDA408D-17D0-45B3-8CB9-DC65C78D094B Q24794527-4820847E-BA6E-4467-80AE-E34DED5867ED Q28071831-DAB5437C-4024-4661-B603-9EDAAB48A375 Q28390125-11D7635E-F238-4A2B-9B59-DDFDE3DD58FB Q28392274-D0662970-F4C8-4F45-A6A4-D73A653D2D8B Q30276073-E95CB2A0-B39E-46EA-832C-F1CB5DB8B4D0 Q30447195-0712793E-4B73-4928-BA94-318C6FF8C43A Q30613061-17423C24-F23E-4ABF-8B9C-18558EC81C3E Q33213762-3FAD39A2-1B93-4097-9461-D06C190A803B Q33246694-773AF2E6-E080-49B1-9F6E-1CC259BA75DB Q33450151-E937362C-173D-426B-985A-CF78EA097192 Q33664193-2C779A1B-5CF3-411B-9CEE-6592EEA6D9B7 Q33723544-EE3EAFBA-8775-4F61-B395-DE6CCA4DB421 Q34004412-360C934C-F5C0-45A4-B615-F714884F7E07 Q34004466-3A80ECD6-7FA4-489D-B4EF-2E0412634FBD Q34342101-84589B17-D54B-4496-B01A-7923379A077F Q34392656-77D1BD38-DD9E-4130-86F7-BB60EA328E71 Q34507621-C6F8F520-2A1D-4C22-9F85-0ACABF5869B6 Q34523871-9BA8CA66-ED7C-47D5-8434-83D965F2FF8B Q35009462-A2D134E4-9B34-47C1-8A4B-0F4F8DEED99D Q35025262-1C5B3B40-C8B4-46DD-9DDB-3CBFE34F7C9C Q35121650-6D630EF0-5E9B-41B5-96DC-E924DBE80599 Q35275503-6AD79FA6-1C43-4623-9F6D-69297A23355B Q35528312-B143234C-D022-4AA8-A774-A1177E89EBC5 Q35536786-5AF35A67-406E-47F5-8B8D-CB7E8881A669

P2860

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

http://www.wikidata.org/entity/Q53344190

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Exacerbations of asthma: a des ...... CET International Study Group.

@en

Exacerbations of asthma: a des ...... CET International Study Group.

@nl

type

label

Exacerbations of asthma: a des ...... CET International Study Group.

@en

Exacerbations of asthma: a des ...... CET International Study Group.

@nl

prefLabel

Exacerbations of asthma: a des ...... CET International Study Group.

@en

Exacerbations of asthma: a des ...... CET International Study Group.

@nl

P1433

Q53344190-5834E53F-AE41-4ABE-81EB-AC74571472A8

P1476

Q53344190-B1685252-83DF-451D-85D7-13E7D2FF073A

P2093

Q53344190-02E6649B-438B-40C7-84EF-DFB76E9CA7FC

Q53344190-252FC2C8-EC23-4800-9A0D-25FEE5C73B42

Q53344190-485D8996-B95F-466A-A7BF-9DDB4E88274B

Q53344190-6B30113D-A05F-4DDF-8999-E6036C070910

Q53344190-738A614B-2065-47AE-BEE4-92F0D06B466C

Q53344190-89118C87-CA4E-4F42-A6FB-B03E32B04200

Q53344190-AAEF29A1-A1FA-491D-9F25-F125E30866CB

Q53344190-D18B62E6-2B1B-4CC2-99E1-666B85EF9CEF

Q53344190-E5F2F541-7BD0-4653-85B9-D2AF43E53822

P2860

Q53344190-12C96B9F-2F24-4B99-A279-F4B5AEDD0529

Q53344190-17900370-6E71-48B8-B86A-FBF93C4F3217

Q53344190-47B4EAA3-3209-4AAF-9A8F-CC1FCF0D7C3F

Q53344190-4B12AB8D-0DFE-4316-9F0B-94D5EBEAB970

Q53344190-5FF58E78-EC79-47B7-8B42-7B0DA480534E

Q53344190-67C3E228-55B6-4079-B3A5-3EC60069E615

Q53344190-6805877C-AF73-4A4D-9697-6EB52E0A6F7B

Q53344190-A8D14CF4-E1C8-46A2-9DE3-EF1F9EBB6F80

Q53344190-AA33C2AF-F260-4E47-ADCA-9BC626AA5BFC

Q53344190-CEC1287A-8E45-4AF8-836C-FB7649432FD1

P304

Q53344190-802F192F-35AE-4D19-A067-9FC2FF606378

P31

Q53344190-F62F4C22-7CD4-469C-9442-E7927D3AE13C

P356

Q53344190-BB4C2139-DAF6-43B4-8CB4-E6362701CC60

P407

Q53344190-CF5C4283-7E39-49D9-810A-B5730F59BA10

P433

Q53344190-420AEEA3-E7D3-451C-BD4B-4B9144133156

P478

Q53344190-D4CC8F68-8233-4FF6-9109-123B2D028D8A

P577

Q53344190-FB24A34F-689D-4913-A548-DFD78BF10273

P5875

Q53344190-114E3012-BF0D-4A34-A34A-1D5134A5F02E

P698

Q53344190-CB2B1712-1FEC-4D8C-8410-0B526D6096CA

P921

Q53344190-A375F1DE-E420-4F9C-A86E-21F1E0640FD2

P356

AJRCCM.160.2.9811100

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Exacerbations of asthma: a des ...... CET International Study Group.

@en

P2093

A E Tattersfield

http://www.w3.org/2001/XMLSchema#string

A Ullman

http://www.w3.org/2001/XMLSchema#string

C A Bauer

http://www.w3.org/2001/XMLSchema#string

C G Löfdahl

http://www.w3.org/2001/XMLSchema#string

D S Postma

http://www.w3.org/2001/XMLSchema#string

K Svensson

http://www.w3.org/2001/XMLSchema#string

P J Barnes

http://www.w3.org/2001/XMLSchema#string

P M O'Byrne

http://www.w3.org/2001/XMLSchema#string

R A Pauwels

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Heart Study Group.

The influence of age and sex on asthma admissions.

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

Rates of admission to hospital for asthma

Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma.

Regular inhaled beta-agonist treatment in bronchial asthma.

Effects of corticosteroids in acute severe asthma

Characteristics of patients with asthma within a large HMO: a comparison by age and gender.

Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma.

Potential masking effects of salmeterol on airway inflammation in asthma.

P304

594-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/AJRCCM.160.2.9811100

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280291935

http://www.w3.org/2001/XMLSchema#string

P698

10430734

http://www.w3.org/2001/XMLSchema#string

P921